Kaitlyn Izzo

Kaitlyn Izzo is a Senior Research Associate at Tessera Therapeutics, with extensive experience in cellular and molecular biology. Prior roles include Associate Scientist at Editas Medicine, where Kaitlyn generated edited iPSC lines using CRISPR technology and established assays for assessing NK cell performance. Previous positions also involve T Cell Immunology work at Neon Therapeutics, technical research at Harvard Medical School, and various teaching and research roles at Northeastern University. Kaitlyn holds a Master's degree in Biotechnology and a Bachelor's degree in Biology from Northeastern University.